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Abstract
Background: There is increasing emphasis on primary care services for individuals with severe mental illnesses (SMI),
including schizophrenia, bipolar disorder, and other non-organic psychotic disorders. However we lack information on how
many people receive these different diagnoses in primary care. Primary care databases offer an opportunity to explore the
recording of new SMI diagnoses in representative general practices.
Methods: We used data from The UK Health Improvement Network (THIN) primary care database including longitudinal
patient records for individuals aged over 16 years from 437 general practices. We determined the annual GP recorded rate
of first diagnosis of SMI by age, gender, social deprivation and urbanicity between 2000 and 2010.
Results:We identified 10,520 individuals with a first record of schizophrenia, bipolar disorder or other non-organic psychosis
among 4,164,794 patients. This corresponded to a rate of first diagnosis of 46.4 per 100,000 person years at risk (PYAR) (95%
CI 45.4 to 47.4) in the 16–65 age group. The rate of first record of schizophrenia was 9.2 per 100,000 PYAR (95% CI 8.7 to 9.6)
in this age group, bipolar disorder was 15.0 per 100,000 PYAR (95% CI 14.4 to 15.5) and other non-organic psychotic
disorder was 22.3 per 100,000 PYAR (95% CI 21.6 to 23.0).
Conclusions: The rates of GP recorded SMI in primary care records were broadly comparable to incidence rates from
previous epidemiological studies of SMI and show similar patterns by socio-demographic characteristics. However there
were some differences by specific diagnoses. GPs may be recording rates that are higher than those used to commission
services.
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Introduction
Individuals with Severe Mental Illness (SMI); defined as
schizophrenia, bipolar disorder and other non-organic psychotic
conditions, in keeping with the Quality Outcomes Framework [1],
constitute around 2% of the population (lifetime prevalence) [2].
Recent epidemiological studies have confirmed that SMI inci-
dence is related to sex, migrant status, urbanicity, season of birth,
and economic status [3–5], but it is now clear that there is
significant heterogeneity across populations [6–8]. A recent meta-
analysis of English studies from 1950–2009 showed a pooled
incidence of 31.7 per 100,000 person years at risk (PYAR) for all
psychotic illness[8] with a range from 21 to 50 per 100,000 PYAR
[9,10] Specifically, schizophrenia incidence is around 15 per
100,000 PYAR [11] and affective psychosis 12 per 100,000 PYAR
[8].
Accurate incidence data are vital for planning service provision
in both primary and secondary care [12], for understanding any
underlying changes in the SMI population over time, and to
contextualise and validate SMI research which utilises primary
care clinical data. However we lack contemporary information on
SMI incidence rates in the UK, either in the community or in
primary care settings. There is one existing study using primary
care data to examine changes in new recording of psychotic
disorder [13]. This study suggested rates remained stable over a
ten-year period (1996–2005) and its inclusion criteria (which
include chronic disorders and symptoms such as ‘‘paranoia’’) are
likely to have produced an overestimate of SMI.
In the United Kingdom, the care of people with SMI is included
in the GP contract [1]. Since 2004 this has been included in Quality
and Outcomes Framework (QOF), whereby practices receive remu-
neration for keeping a register of people who have a diagnosis of
SMI and for offering them an annual review. The implementation
of QOF should mean that SMI is recognised and recorded more
frequently. Care may be provided by the GP alone or in
conjunction with secondary services, either Early Intervention
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Services (traditionally for under 35 year-olds within three years of
a first episode of psychosis) or General Adult Services (under 65
years old) [14].
Our main objective was to estimate number of individuals with
a new record of schizophrenia, bipolar disorder and other non-
organic psychotic conditions in primary care annually between
2000 and 2010, using data from The Health Improvement
Network (THIN) database, a UK primary care database. We also
aimed to examine the recording of these diagnoses by socio-
demographic factors such as age, gender, social deprivation and
urbanicity.
Materials and Methods
Data Source
The Health Improvement Network (THIN) database is one of
the largest UK sources of continuous primary care data,
containing information on illness recording and prescribing
behaviour. At the time of data collection from THIN (http://
csdmruk.cegedim.com) 437 participating general practices, con-
tributing more than 10 million patients, were included. The
database is broadly representative of the UK population [15]. In
the UK most people with SMI are registered with primary care
[16] and the validity of general practice computer diagnoses of
SMI has been established previously [17]. THIN data have also
been shown to be roughly representative of UK general practice in
terms of consultations and prescribing statistics [18,19]. THIN
contains records of each patient’s medical conditions and
symptoms, recorded during routine consultations and all prescrip-
tions issued by GPs. Symptoms and diagnoses are classified using
the Read code system, a hierarchical recording system used to
record clinical summary information [20]. This creates a
computerised medical history for each patient from the time they
register with a general practice. In addition, the database holds
information on basic demographics, urbanicity and social
deprivation. Based on their residential postcode, patients are
classified as residing in urban areas (population .10,000); or in
towns and fringes; or in villages, hamlets and isolated areas. Social
deprivation is measured using the Townsend score for the
postcode sector area of residence, linked to population census
data from 2001 [21]. It is a combined measure of owner-
occupation, car ownership, overcrowding and unemployment
[22]. The scores are defined for small areas of around 150
households, and grouped into quintiles.
Ethics Statement
The scheme for THIN to obtain and provide anonymous
patient data to researchers was approved by the National Health
Service South-East Multicentre Research Ethics Committee
(MREC) in 2002 and scientific approval for this study was
obtained from CMD Medical Research’s Scientific Review
Committee in March 2012.
Study Population
We included data from the date at which practices had met
quality assurance criteria, namely continuously acceptable com-
puter usage (ACU) (i.e. one medical record, one additional health
data record per patient per year, and at least two prescriptions, on
average per patient per year [23]) and the criteria for acceptable
mortality reporting (AMR) which indicate a point at which the
observed death rate for a practice corresponds to that expected
based on predicted numbers of deaths derived from National
statistics given the practice’s demographics [24,25].
We included all individuals aged 16 to 95 years, permanently
registered for at least one year during the period from 1 January
2000 to 31 December 2010. We examined two subgroups
according to age criteria: those traditionally eligible for entry to
Early Intervention Services in the UK (16 to 35 years old)[26,27]
those eligible for entry to General Adult psychiatric services (16 to
65 years old).
For this study we were interested in individuals who had a first
recording suggestive of a new diagnosis of SMI in their primary
care records. Therefore we excluded patients who had a record of
SMI prior to start of follow-up (see details of follow-up in statistical
analysis) or whose first SMI record during follow-up was indicative
of pre-existing SMI or repeated episodes (such as chronic paranoid
schizophrenia, or manic relapse). We also excluded diagnoses
made within the first year of registration, as people who received a
code within the first year were more likely to be prevalent rather
than incident cases [28].
Measurement of main outcome
Cases of SMI included those who had new records of a Read
code for SMI (schizophrenia, bipolar disorder, other non-organic
psychotic illness). A list of all SMI diagnoses was constructed using
established methods [29] and cross-checked with lists of codes
given in national QOF guidance.
SMI Patients were classified according to the type of diagnosis
(schizophrenia, bipolar disorder, other non-organic psychosis). If
patients first received a code for ‘‘other psychosis’’, but had
subsequent codes to indicate schizophrenia or bipolar disorder,
they were reclassified as schizophrenia or bipolar accordingly.
However, the date of the first diagnosis was retained as the date of
the first record. Similarly, if patients first received a code to
indicate inclusion on an SMI register, they were reclassified as
schizophrenia, bipolar or other psychosis if they received these
diagnoses subsequently. If patients received both bipolar and
schizophrenia diagnoses, they were coded as their latest diagnosis
(as this was considered likely to be most accurate, having
considered the whole longitudinal medical history). Patients with
no diagnostic codes at any time but with codes to indicate
inclusion on an SMI register were excluded from the analysis.
Patients receiving a diagnosis code of dementia within a year of
their SMI code were excluded.
The number of individuals with a newly recorded diagnosis was
determined by age (10 year age groups and service-line groups),
sex, urbanicity and quintiles of Townsend score. Individual level
ethnicity was not well recorded historically in THIN, therefore it
was not possible to describe recording by this covariate.
Statistical Analysis
The recording of coded SMI was estimated per 100,000 person
years at risk (PYAR) as the total number of new SMI cases
recorded between 2000 and 2010, divided by the total number of
person years of follow-up. Person-time for the denominator was
estimated as the latest of: [16th birthday, one year’s registration,
ACU/AMR date, start date of period], to the earliest of: [date of
first incident diagnosis, date of death, date patient leaves practice,
date of last data collection from the practice, end date of
period].Recorded rates of all SMI and of different forms of SMI
(schizophrenia, bipolar disorder, other psychosis) were estimated,
according to age, gender, Townsend score and urbanicity.
Annual rates were graphed to examine the time trends.
Multivariable Poisson regression models with (log) person-time as
an offset, were used to examine recording of all SMI by gender,
age (in 10 year age-bands) deprivation (quintiles of Townsend
scores) and urbanicity (as three categories: urban, town/fringe and
UK Recording of Severe Mental Illness
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village/hamlet/isolated). Multilevel random intercept models were
used to account for clustering of patients in practices. All analyses
were carried out using STATA 12.
Results
In total, 10,520 individuals (amongst 4,164,794 patients) had an
electronic record indicating that they had a new diagnosis of
severe mental illness between 2000 and 2010. This was equivalent
to 44.9 per 100,000 PYAR (95% Confidence Interval (CI) 44.0 to
45.7). There were substantial differences by age and sex within
different diagnoses. Of the diagnoses made, 18% were classified as
schizophrenia, 30% bipolar disorder and 52% other non-organic
psychotic disorder. For the 16–65 age group (eligible for General
Adult Services) the rate of recording was 46.4 per 100,000 PYAR
(95% CI 45.4 to 47.4) and for the 16–35 age group (eligible for
Early Intervention Services) the rate of newly recorded diagnoses
cases was 58.1 per 100,000 PYAR (95% CI 56.3 to 60.0).
Schizophrenia
Schizophrenia was the least commonly recorded diagnosis of
severe mental illnesses in primary care records. Up to 2004, there
were between 10 and 14 new entries per 100,000 PYAR.
However, by 2007 there were only around 5 new entries per
100,000 PYAR (Figure 1). In the 16–65 age group the rate was 9.2
per 100,000 PYAR (95% CI 8.7 to 9.6) and in the 16–35 age
group it was 14.3 Per 100,000 PYAR (95% CI 13.4 to 15.3).
Schizophrenia was more commonly recorded in men than women
(adjusted IRR 0.6, 95% CI 0.54 to 0.66) (Table 1). In men the
diagnosis was most commonly recorded in the 16–24 age group
and recording reduced with increasing age, whereas in women
there was no difference across age groups after adjustment for
other factors (Table 2). Recording of schizophrenia increased with
increasing social deprivation such that individuals in the most
deprived quintile of Townsend score were nearly 5 times more
likely to receive a diagnosis of schizophrenia, than those in the
least deprived quintile (Table 1). After accounting for age, sex and
social deprivation there was no difference in recording of
schizophrenia in urban versus rural areas (Table 1).
Bipolar disorder
Recording a new diagnosis of bipolar disorder ranged between
11 and 19 per 100,000 PYAR between 2000 and 2010, with a
peak around 2004. However, by 2010 nearly 3 times as many
people had a new record of bipolar as of schizophrenia (Figure 1)
In the 16–65 and 16–35 subgroups bipolar disorder was recorded
at a rate of 15.0 per 100,000 PYAR (95% CI 14.4 to 15.5) and
14.8 per 100,000 PYAR (95% CI 13.9 to 15.8) respectively over
the period of study. In contrast to schizophrenia recording of
bipolar disorder was more commonly recorded in women than
men (Table 1). For men the first diagnosis was commonly recorded
between the ages of 35–44 years, whereas women were diagnosed
earlier (most commonly between 25–34 years) (Table 2). Like
schizophrenia, recorded bipolar disorder increased with increasing
social deprivation and the most deprived quintile was almost twice
as common as the least deprived (Table 1). After accounting for
age, sex and social deprivation there was no difference in
recording of bipolar disorder in urban versus rural areas (Table 1).
Other psychosis
Compared to schizophrenia and bipolar disorders a larger
group had a record of non-organic psychotic illnesses (Figure 1).
An increasing number of individuals received such diagnosis
between 2000 and 2004. Thereafter, the recording fell to around
20 per 100,000 person years with an increase in 2010. It was
recorded at a rate of 22.3 per 100,000 PYAR (95% CI 21.6 to
23.0) in the 16–65 age group, and 29.1 per 100,000 PYAR (95%
CI 27.8 to 30.4) in the 16–35 age group. Similar to schizophrenia,
recording was highest for men in the 16–24 age group, but for
women the recording increased over 75 years old (Table 2). Again
there was an increase in recording with increasing deprivation;
with nearly three times as many individuals in the most deprived
group, and no statistically significant relationship with urbanicity
(Table 1).
Diagnosis stability
For the majority of individuals with a record of SMI (90.3%)
there was no discrepancy in diagnosis codes assigned over the 10
year study period (Table 3). However for those who had an initial
Figure 1. Time trends in GP recorded diagnosis of schizophrenia, bipolar disorder and other psychosis.
doi:10.1371/journal.pone.0082365.g001
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record of non-organic psychosis 8.0% were subsequently coded as
schizophrenia and 3.4% for bipolar disorder. A switch in code
from bipolar to schizophrenia or vice versa occurred in 1.5% of
the individuals (Table 3).
Discussion
We present data on over 10,000 newly recorded SMI diagnoses
(schizophrenia, bipolar disorder and other non-organic psychosis)
in routine primary care settings across the UK between 2000 and
2010. Over this time, recorded rate of all SMI among those aged
16 to 94 years was 44.9 per 100,000 PYAR (95% CI 44.0 to 45.7).
This study is the first to provide data on rate of recorded
schizophrenia, bipolar disorder and other non-organic psychotic
disorders in a large cohort of people seen in primary care over
time. A recent meta-analysis [8] examining incidence in individ-
uals under 65 years old, highlights the heterogeneity of incidence
rates in psychotic disorders in England. Our recorded SMI rate for
16–65 year olds (46.4 per 100,000 PYAR, 95% CI 45.4 to 47.4)
falls just above the confidence intervals of the incidence rate of all
forms of psychotic illness in this meta-analysis (24.6 to 40.9 per
100,000 PYAR). Table 4 highlights how our findings fit with
previous studies. Many previous studies examined incidence rate
of first episode of psychosis in secondary care (with varying
definitions of age of onset such as ‘‘first presentation’’, ‘‘first
contact’’ and ‘‘hospitalisation’’, or a retrospective onset date), and
often in a particular subgroup (for example those engaged in, or
referred to, Early Intervention Services). By contrast our sample
differs since they represent newly recorded cases in primary care
throughout the UK. Not all patients with SMI are diagnosed or
treated in secondary care this may be a reason why the rate is
higher in this study than studies originating from hospital settings.
It may also be the case that an individual with SMI is more likely
to be registered with a GP than the general population. The other
existing study to use primary care data [13] used the General
Table 2. Recording of rate of individual diagnosis by age and gender.
Schizophrenia
Rate per 100,000 PYAR (95% CI) Adjusted* IRR (95% CI) p{
Age, years Men Women Men Women ,0.001
16–24 24.7 (22.3 to 27.4) 7.3 (6.0 to 8.9) 1 1
25–34 17.1 (15.3 to 19.2) 7.9 (6.7 to 9.4) 0.67 (0.57 to 0.78) 1.17 (0.88 to 1.56)
35–44 10.0 (8.8 to 11.4) 6.6 (5.6 to 7.8) 0.42 (0.35 to 0.50) 1.08 (0.81 to 1.44)
45–54 7.1 (6.0 to 8.3) 5.4 (4.5 to 6.6) 0.30 (0.24 to 0.37) 0.90 (0.67 to 1.23)
55–64 4.5 (3.6 to 5.5) 4.5 (3.6 to 5.6) 0.21 (0.16 to 0.27) 0.77 (0.55 to 1.07)
65–74 3.6 (2.7 to 4.8) 5.0 (4.0 to 6.4) 0.15 (0.11 to 0.22) 0.82 (0.58 to 1.15)
75–84 2.9 (1.9 to 4.4) 6.3 (4.9 to 8.0) 0.13 (0.08 to 0.21) 0.96 (0.68 to 1.36)
85–94 4.4 (2.2 to 8.8) 7.2 (5.0 to 10.4) 0.19 (0.09 to 0.39) 0.91 (0.56 to 1.47)
Bipolar disorder
Age, years Men Women Men Women ,0.001
16–24 10.1 (8.6 to 11.9) 13.4 (11.5 to 15.5) 1 1
25–34 12.0 (10.5 to 13.7) 22.5 (20.4 to 24.9) 1.23 (0.98 to 1.54) 1.59 (1.32 to 1.93)
35–44 13.6 (12.2 to 15.2) 21.6 (19.8 to 23.7) 1.39 (1.13 to 1.73) 1.54 (1.28 to 1.86)
45–54 12.9 (11.4 to 14.6) 19.0 (17.2 to 21.0) 1.34 (1.07 to 1.66) 1.40 (1.16 to 1.70)
55–64 9.2 (7.9 to 10.7) 12.7 (11.2 to 14.5) 1.00 (0.78 to 1.27) 0.99 (0.80 to 1.22)
65–74 8.3 (6.8 to 10.0) 10.2 (8.6 to 12.0) 0.87 (0.67 to 1.15) 0.73 (0.57 to 0.93)
75–84 6.2 (4.6 to 8.3) 9.3 (7.6 to 11.4) 0.65 (0.46 to 0.93) 0.69 (0.53 to 0.90)
85–94 6.0 (3.3 to 10.9) 5.2 (3.4 to 8.0) 0.57 (0.29 to 1.13) 0.41 (0.26 to 0.65)
Other Psychosis
Age, years Men Women Men Women ,0.001
16–24 41.2 (38.0 to 44.6) 21.7 (19.4 to 24.4) 1 1
25–34 30.5 (28.0 to 33.1) 23.0 (20.9 to 25.4) 0.73 (0.64 to 0.83) 1.01 (0.86 to 1.20)
35–44 22.4 (20.5 to 24.4) 22.1 (20.3 to 24.2) 0.55 (0.48 to 0.63) 1.05 (0.90 to 1.24)
45–54 16.3 (14.7 to 18.2) 21.0 (19.1 to 23.1) 0.42 (0.36 to 0.48) 1.04 (0.88 to 1.22)
55–64 12.8 (11.3 to 14.6) 16.2 (14.5 to 18.2) 0.34 (0.29 to 0.41) 0.82 (0.69 to 0.98)
65–74 12.8 (11.0 to 15.0) 21.4 (19.1 to 24.0) 0.34 (0.28 to 0.41) 1.06 (0.89 to 1.26)
75–84 21.4 (18.3 to 25.0) 36.1 (32.6 to 40.0) 0.55 (0.45 to 0.67) 1.73 (1.47 to 2.05)
85–94 31.9 (24.6 to 41.2) 65.3 (57.8 to 73.7) 0.77 (0.57 to 1.03) 3.10 (2.59 to 3.71)
*from multilevel Poisson regression, with patients nested in practices, adjusting for the other variables considered.
{for age-gender interaction.
doi:10.1371/journal.pone.0082365.t002
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Practice Research Database (GPRD) to identify a cohort with first
onset of psychotic illness and found an incidence of 65 per 100,000
PYAR. However they did not apply the rigorous inclusion/
exclusion criteria of our study.
Our recorded rate of schizophrenia (8.2 per 100,000 PYAR)
was lower than in population incidence studies (Table 4), but it is
possible that many patients fulfilling criteria for schizophrenia
were coded in the other non-organic psychosis group; this
diagnosis has become increasingly common with development of
Early Intervention Services who are wary of diagnosing schizo-
phrenia early in the illness [30]. This trend has also been
recognised in GPRD [13]. The data are consistent with established
epidemiological trends for schizophrenia; namely that it is more
common in men than women [31], most commonly diagnosed in
the 16–25 year age band [32], and an increasing incidence with an
increase in social deprivation [12]. However after adjustment the
difference by urbanicity was non-significant [31].
The recorded rate of bipolar disorder (13.6 per 100,000 PYAR)
was higher than in other UK studies, but contemporary UK
incidence data on bipolar disorder is limited (Table 4) and recent
Table 3. Changes in diagnoses code.
Diagnosis ultimately assigned* N (%)
Schizophrenia Bipolar Other SMI register Total
First record of SMI Schizophrenia 1,257 (98.5) 19 (1.5) 0 (0) 0 (0) 1,276
Bipolar 42 (1.5) 2,703 (98.5) 0 (0) 0 (0) 2,745
Other 468 (8.0) 198 (3.4) 5,144 (88.5) 0 (0) 5,809
SMI register 163 (3.4) 257 (5.3) 270 (5.6) 4,151 (85.8) 4,841
Total 1,930 3,177 5,413 4,151 14,671
*Among patients whose first SMI record is for other psychosis, those who subsequently received a diagnosis of bipolar disorder or schizophrenia are re-classified as
such. Among patients whose first SMI record indicates inclusion on an SMI register, those who subsequently received a diagnosis of schizophrenia, bipolar disorder or
other psychosis are re-classified as such. Patients whose first record is for schizophrenia are re-classified as bipolar disorder if they subsequently received a bipolar
disorder diagnosis and vice-versa (since the more recent record may be seen as the most accurate diagnosis).
doi:10.1371/journal.pone.0082365.t003
Table 4. UK based population incidence estimates using data collected between 1995–2010.
First Author
Publication
year
Data collection
years Setting
Number of
patients
Incidence (per
100,000 PYAR)
95% CI (per
100,000 PYAR)
ALL SMI
Hardoon 2013 2000–2010 ALL UK 8571 46.4 45.4–47.4
Reay 2010 1999–2005 Northumberland 441 31.0 27.2–33.2
Coid 2008 1997–1999 East London 484 58.4 53.4–63.9
Gould 2006 2002 North London 111 30.0 24.9–36.1
Kirkbride 2006 1997–1999 London/Bristol/Nottingham 568 34.8 32.1–37.8
Mahmood 2006 2001–2005 South London 303 100.0 N/A
Proctor 2004 1998–2001 Northumberland 227 30.4 26.4–34.3
Singh 2003 2000 West/South London 295 21.0 18.7–23.5
Scully 2002 1995–2000 County Cavan, Ireland 69 18.7 14.6–23.7
Rowlands 2001 1999 Derbyshire 84 36.0 29.1–44.6
Schizophrenia
Hardoon 2013 2000–2010 ALL UK 1694 9.2 8.7–9.6
Reay 2010 1999–2005 Northumberland 60 17.0 15.0–19.0
Coid 2008 1997–1999 East London 268 32.4 28.7–36.5
Kirkbride 2006 1997–1999 London/Bristol/Nottingham 209 12.0 11.2–14.7
Proctor 2004 1998–2001 Northumberland 128 17.1 6.4–34.3
Scully 2002 1995–2000 County Cavan, Ireland 35 9.5 6.6–13.2
Bipolar Disorder
Hardoon 2013 2000–2010 ALL UK 2762 15.0 14.4–15.5
Reay 2010 1999–2005 Northumberland 44 3.2 2.4–4.4
Lloyd 2005 1997–1999 London/Bristol/Nottingham 75 4.6 2.7–5.8
Scully 2002 1995–2000 County Cavan, Ireland 8 2.2 0.9–4.3
Adapted from [8].
doi:10.1371/journal.pone.0082365.t004
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studies have low patient numbers (less than 100 cases). In the US
the incidence of bipolar disorder has been found to be as high as
500 persons per 100 000 PYAR [33]. In studies of European
populations the incidence of those who sought treatment for
bipolar disorder (15 years of age or older) varied from 9.2 to 15.2
males and from 7.4 to 32.5 females per 100 000 PYAR [34–36]
which is more consistent with our findings. Concerns about
increasing diagnosis of bipolar disorder over time [37,38] are not
borne out by our results. Bipolar disorder coding followed patterns
seen in community samples: more common in women [39](per-
haps representing more frequent bipolar II disorder and increased
treatment), later diagnosis than schizophrenia [40], and similar
increases in deprived [41]and urban populations (though this was
not significant after adjustment in our sample) [42].
‘‘Other non-organic psychosis’’ codes are the most common
method of recording psychosis in primary care, which may reflect
hesitancy to assign a diagnosis that could be considered
stigmatising. This may be particularly true for patients who do
not initially show a clear presentation of bipolar disorder or
schizophrenia and for whom a firm diagnosis may be premature.
Whilst many of these patients may ultimately be diagnosed with
bipolar disorder or schizophrenia, others may show no further
symptoms or receive a different diagnosis such as drug-induced
psychosis or schizoaffective disorder. The ‘‘other non-organic
psychosis’’ group is unusual in that in males it follows age of onset
patterns seen in schizophrenia, but in females appears to be
picking up other types of diagnosis (such as delusional disorder or
‘‘paraphrenias’’) being most common over the age of 75. Of the
cohort initially assigned an ‘‘other non-organic psychosis’’
diagnosis 8.0% were eventually coded as having schizophrenia.
The high stability (90.3%) of SMI diagnosis is in keeping with
previous studies [43,44].
Early intervention Services in the UK were established with the
expectation that they would be providing care to 15 new patients
per 100,000 population each year [14].This study suggests the
number of patients fulfilling criteria could be as high as 58.1 per
100,000 PYAR, and therefore that service provision to this
vulnerable cohort may not be sustainable.
Strengths and Limitations
A key strength of this study is the large size of the population
sample (over 4 million patients) enabling precise estimates of rates
of recording in primary care. Furthermore, THIN covers the
whole UK and is broadly demographically representative of UK
primary care patients [18].
There are multiple challenges in estimating incidence from
dynamic, longitudinal GP records. We defined our cases by Read
code diagnosis as we were looking specifically at GP-recorded
SMI, so these patients may not be regarded as ‘‘cases’’ in terms of
standardised diagnostic criteria (ie ICD-10 or DSM-5) however
previous research has found the diagnosis of psychosis (based on
clinician reported Read codes) to be valid [17]. Because of the
nature of the data, we can only state that these are newly recorded
cases, rather than true incident cases of SMI; however we
attempted to reduce the chance of prevalent cases being recorded
as new by excluding those registered for less than one year and
excluding Read codes suggestive of chronic illness (e.g. ‘‘chronic
schizophrenia’’).
People who received a prescription for an antipsychotic
medication without an SMI code being entered were excluded,
as it was unclear what the GP’s working diagnosis was in such
cases. This group would include those prescribed antipsychotic
medication for another indication, such as behavioural distur-
bance, dementia or severe obsessive compulsive disorder.
The data are limited to GP-recorded SMI in-practice attendees,
which reflect incidence, presentation and recording at a practice
level only. Therefore it is possible that some individuals (especially
younger men [45]) have been missed, as they are not registered
with a GP which would be likely to disproportionately reduce the
total population at risk in comparison to the number of cases (as
individuals with SMI are highly likely to be registered with a GP).
There is also a possibility that the patients detected (especially in
older age groups) had a previous diagnosis of SMI, but that this
was not recorded when they later moved into a THIN
contributing practice. We attempted to limit this by excluding
individuals coded within one year of registration. There may be
SMI symptoms coded in free text, which would suggest our
findings may be an underestimate of the true burden of disease in
primary care. The rates we found are however, higher than that
found in other studies identifying people mainly in secondary care
settings. A number of patients (4,151) were coded as being
included on the general practice SMI register, but were not picked
up by our Read code list search, and as a result we excluded them
from the analysis. We have not determined why these patients are
included on the SMI register without also having an SMI
diagnosis, but it may be that GPs have also coded as SMI those
patients with mental health problems who require a lot of input
but don’t truly meet the defined criteria of schizophrenia, bipolar
disorder or other psychotic illness (such as chronic recurrent
depression, anxiety or personality disorder). There are no formal
checks made on who is added to the SMI register and there is
evidence that there was confusion around the definition early on
[1]. Peaks in the recording of each specific diagnosis in the year
QOF was introduced (2004) suggest that GP’s did a ‘catch-up’ of
recording and that some of these were actually prevalent cases
rather than newly diagnosed.
Another limitation is the lack of recording of ethnicity in
primary care. Recording of ethnicity has improved since 2005, in
particular for newly registered patients. However, there is still a
large proportion without information [46]. Therefore, we did not
make an attempt to establish whether certain ethnic groups were
more likely to have a record of psychotic illnesses as shown
elsewhere [8].
Conclusions
We have shown 1) that the overall rate of new recording of SMI
in THIN is slightly higher than SMI incidence in UK community
epidemiological studies, 2) that rates of specific diagnosis differ, but
that they are in keeping with international estimates and show
changes in ‘‘labelling’’ of specific SMIs, and 3) that, after
considering age/sex interaction the socio-demographics of our
cohort fit established patterns. In combination these factors
confirm the suitability of THIN data as a resource for future
research into SMI. A peak in recording occurred in 2004 which
may in part reflect updating of primary care records at the time of
the introduction of QOF for SMI. After the introduction of QOF,
rates remained stable at around 40 new cases per 100,000 person
years, more likely representing the true numbers of new cases in
primary care. Schizophrenia is more rarely coded than population
estimates of incidence in existing studies, and is reducing over
time. Bipolar disorder is more commonly coded but rates
remained relatively stable over the study period. Our findings
suggest that rates of SMI among the 16 to 35 year age group might
be higher than that anticipated in development of Early
Intervention Services.
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